Chemo‐endocrine therapy in patients with stage D2 prostate cancer

The Prostate

Volumn 26, Issue 1, 1995, Pages 50-54

  Kubota, Yoko ^a   Nakada, Teruhiro ^a   Imai, Kyoichi ^b   Yamanaka, Hidetoshi ^b   Sakai, Hideki ^c   Saito, Yutaka ^c   Tomaru, Yukio ^d   Kitamura, Koichi ^d   Sugano, Osamu ^e   Sasagawa, Isoji ^f  

^a YAMAGATA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Kiryu Kousei General Hospital   (Japan)

^e Yamagata Prefectural Central Hospital   (Japan)

^f Yamagata Saisei Hospital   (Japan)

Author keywords

Adriamycin; Cisplatin; prostate cancer

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ALKALINE PHOSPHATASE; CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOSFESTROL; TESTOSTERONE;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TESTOSTERONE BLOOD LEVEL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DIETHYLSTILBESTROL; DOXORUBICIN; HUMANS; MALE; MIDDLE AGED; ORCHIECTOMY; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS;

EID: 0028869873     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.2990260110     Document Type: Article

References (17)

1. Do we have a rational treatment plan for stage D1 carcinoma of the prostate?
2. Advanced prostatic carcinoma: Early versus late endocrine therapy
3. The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer
4. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan
5. Treatment of advanced prostatic cancer
6. Chemotherapy principals in the treatment of prostatic cancer
7. Prostate cancer chemotherapy
8. Chemotherapy for prostate cancer present concerns and future considerations
9. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy studied in the Dunning R‐3327‐H adenocarcinoma
10. The endocrinology and developmental biolgy of the prostate
11. Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone
12. The National Prostatic Cancer Project: Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer
13. The National Prostatic Cancer Project: A comparison of diethylstilbestrol of orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate
14. Combined hormone‐chemotherapy for metastatic prostatic carcinoma
15. Treatment of estrogen resistant stage D adenocarcinoma of the prostate with cis diamminedichloroplatinum
16. A clinical assessment of the role of chemotherapy for endocrine‐resistant prostatic carcinoma
17. Investigators of the National Cancer Project Cooperative Clinical Trials: Cooperative clinical trials of single and combined agent protocols: Adjuvant protocols